These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 32988446)
1. Avoiding acute kidney injury in primary care: attitudes and behaviours of general practitioners and community pharmacists in Hawke's Bay. Vicary D; Hutchison C; Aspden T J Prim Health Care; 2020 Sep; 12(3):244-256. PubMed ID: 32988446 [TBL] [Abstract][Full Text] [Related]
2. Demonstrating the value of community pharmacists in New Zealand educating a targeted group of people to temporarily discontinue medicines when they are unwell to reduce the risk of acute kidney injury. Vicary D; Hutchison C; Aspden T Int J Pharm Pract; 2020 Dec; 28(6):569-578. PubMed ID: 32945014 [TBL] [Abstract][Full Text] [Related]
3. Preventing acute kidney injury: assessing awareness to temporarily discontinue 'at-risk' medicines during acute illness in a New Zealand cohort. Vicary D; Hutchison C; Aspden T N Z Med J; 2020 Jul; 133(1519):12-23. PubMed ID: 32777791 [TBL] [Abstract][Full Text] [Related]
4. Doctors and pharmacists provision and opinions of medicines information leaflets in New Zealand. Young A; Tordoff J; Leitch S; Smith A Int J Clin Pharm; 2018 Jun; 40(3):676-685. PubMed ID: 29675683 [TBL] [Abstract][Full Text] [Related]
5. Hawke's Bay pharmacists' activities during a campylobacter contamination of public water supply in Havelock North during 2016. Vicary D; Salman S; Jones N; Aspden T J Prim Health Care; 2020 Jun; 12(2):122-128. PubMed ID: 32594979 [TBL] [Abstract][Full Text] [Related]
6. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page? Hamrosi KK; Raynor DK; Aslani P Res Social Adm Pharm; 2014; 10(4):656-68. PubMed ID: 24239213 [TBL] [Abstract][Full Text] [Related]
7. Enhancing provision of written medicine information in Australia: pharmacist, general practitioner and consumer perceptions of the barriers and facilitators. Hamrosi KK; Raynor DK; Aslani P BMC Health Serv Res; 2014 Apr; 14():183. PubMed ID: 24754890 [TBL] [Abstract][Full Text] [Related]
8. Solidarity or dissonance? A systematic review of pharmacist and GP views on community pharmacy services in the UK. Hindi AMK; Jacobs S; Schafheutle EI Health Soc Care Community; 2019 May; 27(3):565-598. PubMed ID: 30047617 [TBL] [Abstract][Full Text] [Related]
9. Physician and pharmacist perceptions of generic medicines: what they think and how they differ. Dunne S; Shannon B; Hannigan A; Dunne C; Cullen W Health Policy; 2014 Jun; 116(2-3):214-23. PubMed ID: 24709114 [TBL] [Abstract][Full Text] [Related]
10. General practitioners' views of pharmacists' current and potential contributions to medication review and prescribing in New Zealand. Hatah E; Braund R; Duffull SB; Tordoff J J Prim Health Care; 2013 Sep; 5(3):223-33. PubMed ID: 23998173 [TBL] [Abstract][Full Text] [Related]
11. General practitioners' experiences with, views of, and attitudes towards, general practice-based pharmacists: a cross-sectional survey. Hasan Ibrahim AS; Barry HE; Hughes CM BMC Prim Care; 2022 Jan; 23(1):6. PubMed ID: 35172734 [TBL] [Abstract][Full Text] [Related]
12. GPs' and community pharmacists' opinions on medication management at transitions of care in Ireland. Redmond P; Carroll H; Grimes T; Galvin R; McDonnell R; Boland F; McDowell R; Hughes C; Fahey T Fam Pract; 2016 Apr; 33(2):172-8. PubMed ID: 26984995 [TBL] [Abstract][Full Text] [Related]
13. Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study. Bereznicki B; Peterson G; Jackson S; Haydn Walters E; DeBoos I; Hintz P J Clin Pharm Ther; 2011 Jun; 36(3):348-55. PubMed ID: 21545614 [TBL] [Abstract][Full Text] [Related]
14. Barriers and enablers to collaborative working between GPs and pharmacists: a qualitative interview study. Duncan P; Ridd MJ; McCahon D; Guthrie B; Cabral C Br J Gen Pract; 2020 Mar; 70(692):e155-e163. PubMed ID: 32041767 [TBL] [Abstract][Full Text] [Related]
15. General practitioners' attitudes towards and frequency of collaboration with pharmacists in China: a cross-sectional study. Cai S; Huang X; Van C; Li W; Yan M; Lu Y; Li H; Deng Z; Lu P; Xu Z BMC Health Serv Res; 2023 Oct; 23(1):1174. PubMed ID: 37891601 [TBL] [Abstract][Full Text] [Related]
16. GPs, community pharmacists and shifting professional boundaries. Bidwell S; Thompson L N Z Med J; 2015 May; 128(1414):19-26. PubMed ID: 26117387 [TBL] [Abstract][Full Text] [Related]
17. Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland. O'Callaghan J; Bermingham M; Leonard M; Hallinan F; Morris JM; Moore U; Griffin BT Regul Toxicol Pharmacol; 2017 Aug; 88():252-261. PubMed ID: 28666961 [TBL] [Abstract][Full Text] [Related]
18. General practitioners' perceptions of the current status and pharmacists' contribution to primary care in Iceland. Blondal AB; Jonsson JS; Sporrong SK; Almarsdottir AB Int J Clin Pharm; 2017 Aug; 39(4):945-952. PubMed ID: 28616683 [TBL] [Abstract][Full Text] [Related]
19. The perspectives of parents, general practitioners, and community pharmacists about treating an ill child in primary care: a comparative study. Verhelst S; De Bruyne P; Van Winckel M; Boussery K; Tommelein E Eur J Pediatr; 2020 Jan; 179(1):111-119. PubMed ID: 31659469 [TBL] [Abstract][Full Text] [Related]
20. Improving medicines management for people with dementia in primary care: a qualitative study of healthcare professionals to develop a theory-informed intervention. Barry HE; Bedford LE; McGrattan M; Ryan C; Passmore AP; Robinson AL; Molloy GJ; Darcy CM; Buchanan H; Hughes CM BMC Health Serv Res; 2020 Feb; 20(1):120. PubMed ID: 32059718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]